Intarcia Therapeutics, Inc.

📍 Boston, United States🗓 Founded 1997👥 84 employees💰 Last funded Jun 2013
Biotechnology Research🌐 intarcia.com
Website LinkedIn
We operate with a “No Analog” mindset—continually pushing boundaries, navigating new terrain and unleashing fresh thinking. We are committed to seeking better outcomes which compels us to ask questions that have not been asked before or remain unresolved. We are driven by a desire to create meaningful impact across business, health and society to ease the burden on people living with chronic diseases. Intarcia is a rapidly emerging biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease. Our cross-disciplinary teams include forward-thinking scientists and entrepreneurs collaborating in a fast-paced environment redefining the future of medicine.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1997
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Frequently asked questions
Who invested in Intarcia Therapeutics, Inc.?
Intarcia Therapeutics, Inc. has 1 investors on record on gritt.io.
When did Intarcia Therapeutics, Inc. last raise funding?
The most recent investment in Intarcia Therapeutics, Inc. recorded on gritt.io was in June 2013.
When was Intarcia Therapeutics, Inc. founded?
Intarcia Therapeutics, Inc. was founded in 1997.
What industry is Intarcia Therapeutics, Inc. in?
Intarcia Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Intarcia Therapeutics, Inc. based?
Intarcia Therapeutics, Inc. is headquartered in Boston, United States.